We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002463:SZSEWus Printed Circuit (Kunshan) Co., Ltd. Analysis

Data as of 2026-03-15 - not real-time

CN¥81.18

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Wus Printed Circuit is riding a strong earnings wave, with revenue climbing 25.5% YoY and a robust 20% profit margin that translates into an impressive 29.5% ROE. The stock is trading at a trailing P/E of 45.35, well above the industry average of 33.7, indicating current overvaluation, yet the forward P/E of 23.17 suggests a meaningful re‑rating upside. Technicals are firmly bullish – the price of 81.18 sits above the 20‑day SMA (75.55) and the 50‑day SMA (73.52), the RSI is at 60.7, and the MACD histogram remains positive, with support near 65 and resistance around 85.8. Volatility is elevated (≈59% 30‑day) and the beta is modest (~0.6), while the dividend yield is modest at 0.62% with a low 28% payout, supporting sustainability. The combination of growth momentum, solid cash generation, and a near‑term technical rally makes the stock attractive for medium‑term buyers, though the current valuation and macro‑risk factors counsel caution for long‑term holders.
Given the stable trading volume and ample market cap, liquidity risk is low, but exposure to China’s regulatory environment and global trade dynamics adds medium‑to‑high geographic and regulatory risk. Investors should weigh the upside to analyst median target (≈95 CNY) against the valuation premium and potential sector cyclicality.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price approaching resistance at ~85.8 CNY
  • Bullish SMA crossover and positive MACD
  • Elevated short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E of 23.17 indicating valuation compression
  • Revenue growth of 25.5% and strong ROE
  • Analyst median price target of 95 CNY (~17% upside)

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained dividend with low payout ratio
  • High valuation relative to peers
  • Exposure to Chinese regulatory and trade environment

Key Metrics & Analysis

Financial Health

Revenue Growth25.50%
Profit Margin20.18%
P/E Ratio45.4
ROE29.51%
Debt/Equity35.36
P/B Ratio11.2
Industry P/E33.7

Technical Analysis

TrendBullish
RSI60.7
SupportCN¥65.01
ResistanceCN¥85.80
MA 20CN¥75.55
MA 50CN¥73.52
MA 200CN¥61.86
MACDBullish
VolumeStable
Fear & Greed Index72.88

Valuation

Target PriceCN¥102.44
Upside/Downside26.19%
GradeOvervalued
TypeGrowth
Dividend Yield0.62%

Risk Assessment

Beta0.60
Volatility59.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.